PRQR

#3661
ProQR Therapeutics N.V. Ordinary Shares
1.92 USD
-3.52%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.91
1.92
Rango anual
1.12
3.10
Cambio diario
-3.52%
Variación mensual
+4.35%
Variación en los últimos 6 meses
-29.15%
Cambio anual
+62.71%
Cierres anteriores
1.99
Abrir
1.91
Bid
Ask
Mínimo
1.91
High
1.92
Volumen
37
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q4, 25 TTM

ProQR Therapeutics N.V

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

Noticias